** Macquarie downgrades Australia's Ansell ANN.AX to "Neutral" rating from "Outperform", trims price target to A$31.05 from A$40.30
** The new price target represents 5.6% premium to stock's close on Tuesday
** U.S. tariffs announced on April 4 present downside for ANN, despite the company expecting to fully offset tariff impacts through pricing - Macquarie
** ANN, known for its medical gloves and surgical gowns, has ~93% of its supply chain facing U.S. reciprocal tariffs greater than 10%, Macquarie says
** Two of 10 analysts rate the stock "buy" and eight "hold"; their median PT is A$38.10 – LSEG data
** Stock down 13.1% YTD
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。